A new phase 3 trial shows that DPP-1 inhibition with brensocatib reduces exacerbations and slows lung function decline in ...

The development of gepotidacin was funded by the pharmaceutical company GSK, which is responsible for manufacturing the new ...

The findings raise concern as Darjeeling, Kalimpong draw tourists to West Bengal; ZSI scientists confirmed that no individual ...